Zhizhong Pan

机构：Sun Yat-sen University, Key Laboratory of Guangdong Province, Sun Yat-sen University Cancer Center, Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial People's Hospital, State Key Laboratory of Oncology in South China, Tianjin Medical University, South China University of Technology, Guangzhou Medical University, Huizhou University · ORCID：0000-0002-5198-2919

发表论文 346 篇 · 总被引 6853 次 · h-index 42

代表论文

• Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients (2024 · Nature Communications · 被引 81)
• Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer (2025 · Cancer Letters · 被引 31)
• Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 26)
• DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening (2024 · npj Precision Oncology · 被引 11)
• Development and validation of a logistic regression model for the diagnosis of colorectal cancer (2025 · Scientific Reports · 被引 9)
• Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study (2025 · npj Precision Oncology · 被引 8)